Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53

Prognostic markers and putative therapeutic targets for hepatocellular carcinoma

(2010) Maddalena Frau et al.   MOLECULAR ASPECTS OF MEDICINE

NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53

(2009) D. F. Calvisi et al.   CANCER RESEARCH

B-MYB Is Required for Recovery from the DNA Damage-Induced G2 Checkpoint in p53 Mutant Cells

(2009) M. Mannefeld et al.   CANCER RESEARCH

SKP2 and CKS1 Promote Degradation of Cell Cycle Regulators and Are Associated With Hepatocellular Carcinoma Prognosis

(2009) Diego F. Calvisi et al.   GASTROENTEROLOGY

Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC

(2009) D F Calvisi et al.   GUT

Dual-Specificity Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase-Mediated Control of Growth in Human Hepatocellular Carcinoma

(2008) D. F. Calvisi et al.   CANCER RESEARCH

Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease

(2008) Diego F. Calvisi et al.   CARCINOGENESIS

Molecular targeted therapies in hepatocellular carcinoma

(2008) Josep M. Llovet et al.   HEPATOLOGY